Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-22-010011
Filing Date
2022-07-25
Accepted
2022-07-25 06:51:23
Documents
1
Period of Report
2022-07-25

Document Format Files

Seq Description Document Type Size
1 ULTOMIRIS RECOMMENDED FOR EU APPROVAL FOR GMG a5302t.htm 6-K 47842
  Complete submission text file 0001654954-22-010011.txt   48999
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 221100981
SIC: 2834 Pharmaceutical Preparations